Universitätsklinikum Ulm Zentrum für Innere Medizin
About Universitätsklinikum Ulm Zentrum für Innere Medizin
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Galapagos NV
3
Goethe University
3
Hoffmann-La Roche
3
AIO-Studien-gGmbH
2
Arrowhead Pharmaceuticals
2
Celgene Corporation
2
Martin-Luther-Universität Halle-Wittenberg
2
Pfizer
2
Boehringer Ingelheim
1
EMD Serono
1
Gilead Sciences
1
Clinical Trials at Universitätsklinikum Ulm Zentrum für Innere Medizin
During the past decade, Universitätsklinikum Ulm Zentrum für Innere Medizin conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 8 clinical trials were completed, i.e. on
average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Safety Study of Tipranavir Co-administered With Low-dose Ritonavir (TPV/r) in Patients With Advanced HIV-1 Infection and Limited Treatment Options
2004-05-01
2006-04-01
Completed
255
Safety and Efficacy of Extracorporeal Photoimmune Therapy With UVADEX for the Treatment of Crohn's Disease
2004-12-01
2006-06-01
Completed
25
A Study to Compare MPR With MP in Newly Diagnosed Multiple Myeloma Subjects 65 Years Old or Older.
2007-01-01
2016-04-01
Completed
459
A Multicenter, Single-Arm, Open-Label Expanded Access Program for Lenalidomide Plus Dexamethasone in Previously Treated Subjects With Multiple Myeloma
2007-03-01
2009-08-01
Completed
150
Safety and Tolerability of AP 12009, Administered I.V. in Patients With Advanced Tumors Known to Overproduce TGF-beta-2
2005-01-01
2011-11-01
Completed
62
A Phase I, Dose-escalation Study of AS703569 Given Orally to Subjects With Haematological Malignancies
2006-12-01
2011-08-01
Terminated
124
Minimizing the Risk of Metachronous Adenomas of the Colorectum With Green Tea Extract -MIRACLE-
2011-11-01
2019-07-01
Completed
1,001
TRICC-C (AIO-KRK-0111): BIBF 1120 Versus Placebo in Patients Receiving Oxaliplatin Plus Fluorouracil and Leucovorin (mFOLFOX6) for Advanced, Chemorefractory Metastatic Colorectal Cancer (mCRC)
2011-06-01
2016-12-01
Completed
54
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Universitätsklinikum Ulm Zentrum für Innere Medizin" #1 sponsor was "Galapagos NV" with 3 trials, followed by "Goethe University" with 3 trials
sponsored, "Hoffmann-La Roche" with 3 trials sponsored, "AIO-Studien-gGmbH" with 2 trials sponsored and "Arrowhead Pharmaceuticals"
with 2 trials sponsored. Other sponsors include 12 different institutions and
companies that sponsored additional 19 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Universitätsklinikum Ulm Zentrum für Innere Medizin"
#1 collaborator was "Gilead Sciences" with 3 trials as a collaborator, "Deutsche Krebshilfe e.V., Bonn (Germany)" with 2 trials as a collaborator, "ADIR, a Servier Group company" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "EMD Serono" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were
collaborators in the rest 13 trials.
Clinical Trials Conditions at Universitätsklinikum Ulm Zentrum für Innere Medizin
According to Clinical.Site data, the most researched conditions in "Universitätsklinikum Ulm Zentrum für Innere Medizin" are
"Crohn's Disease" (5 trials), "Gastric Cancer" (2 trials), "Hepatitis B" (2 trials), "Ulcerative Colitis" (2 trials) and "Acute Lymphoblastic Leukemia" (1 trials). Many other conditions were trialed in "Universitätsklinikum Ulm Zentrum für Innere Medizin" in a lesser frequency.
Clinical Trials Intervention Types at Universitätsklinikum Ulm Zentrum für Innere Medizin
Most popular intervention types in "Universitätsklinikum Ulm Zentrum für Innere Medizin" are "Drug" (28 trials), "Other" (2 trials), "Dietary Supplement" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (7 trials), "Filgotinib" (4 trials), "5-Fluorouracil" (2 trials), "Atezolizumab" (2 trials) and "Bevacizumab" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Universitätsklinikum Ulm Zentrum für Innere Medizin
The vast majority of trials in "Universitätsklinikum Ulm Zentrum für Innere Medizin" are
30 trials for "All" genders.
Clinical Trials Status at Universitätsklinikum Ulm Zentrum für Innere Medizin
Currently, there are NaN active trials in "Universitätsklinikum Ulm Zentrum für Innere Medizin".
undefined are not yet recruiting,
4 are recruiting,
3 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 18 completed trials in Universitätsklinikum Ulm Zentrum für Innere Medizin,
undefined suspended trials,
and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Universitätsklinikum Ulm Zentrum für Innere Medizin, 6 "Phase 1"
clinical trials were conducted, 14 "Phase 2" clinical
trials and 11 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".